Clinical Trial

Comparison Between Fentanyl and Dexmedetomidine As Adjuvant to Bupivacaine in Combined IPACK and Adductor Canal Block for Postoperative Analgesia After Knee Surgeries

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 14, 2025 (before its estimated July 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will be undertaken to compare the analgesic effects of of fentanyl versus dexmedetomidine as adjuvant to bupivacaine in combined IPACK and ACB for pain management after total knee arthroplasty.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-29.
Status change: Not Yet Recruiting → Recruiting 2025-01-12
Trial Details
NCT Number NCT06759116
Lead Sponsor Zagazig University
Conditions Analgesia, Postoperative
Enrollment 111 participants
Start Date 2025-01-10
Primary Completion 2025-07-10 (estimated)
Study Completion 2025-08-10 (estimated)
Updated on ClinicalTrials.gov 2025-01-14